Top News Stories November 14 2017

The day’s top news stories from stocks on the GuerillaStockTrading watch list.

Apple Inc. (AAPL)

TASER International, Inc. (AAXN)

  • (11/14) Axon Case Study Reveals the Power of Police Body Camera Footage for Prosecuting Domestic Violence – SCOTTSDALE, Ariz., Nov. 14, 2017 /PRNewswire/ — Axon (AAXN), the global leader in connected law enforcement technologies, today announced a groundbreaking case study demonstrating the effects of body-worn cameras on domestic and family violence (DFV) cases. The case study was conducted in conjunction with the Queensland Police Service (QPS) in Australia. It showed an increase in charges filed, arrests and convictions for DFV cases following a deployment of 5,100 Axon body-worn cameras by the agency.
  • (11/14) AMMO Inc. Appoints Kathy Hanrahan to Board of Directors – SCOTTSDALE, Ariz., Nov. 14, 2017 (GLOBE NEWSWIRE) — AMMO, Inc. (OTC:POWW), a premier technology driven American ammunitions developer, manufacturer and distributor, today announced it has appointed Kathy Hanrahan, a seasoned financial executive, to serve on the Company’s Board of Directors. Kathleen has vast experience in both the public sector as well as in the law enforcement market.  For nearly 15 years, Ms. Hanrahan held a number of key executive positions at TASER International, Inc., now Axon Enterprise, Inc., culminating as chief executive officer of TASER Foundation.  She was chief financial officer during the company’s IPO in 2001 and became chief operations officer in 2003, and then president and chief operating officer in 2006.  Her last position at TASER was as chief executive officer and, concurrently, as co-chairperson for the TASER Foundation for Fallen Officers.  Over the course of her career, Ms. Hanrahan has held several director positions for a number of corporations in both the profit and non-profit sectors, and currently serves on the SentrySix Defense Group board. Ms. Hanrahan commented, “I am very excited to become part …Full story available on Benzinga.com

Abbott Laboratories (ABT)

  • (11/14) High-Level Earnings Momentum Keep Abbott Laboratories (ABT) a Buy – InvestorPlace – Stock Market News, Stock Advice & Trading Tips Currently, Abbott Laboratories (NYSE:ABT) has a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier’s investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 2 months. The post High-Level Earnings Momentum Keep Abbott Laboratories (ABT) a Buy appeared first on InvestorPlace.

Acacia Communications, Inc. (ACIA)

AECOM (ACM)

Advanced Micro Devices, Inc. (AMD)

AMN Healthcare Services Inc (AMN)

TD Ameritrade Holding Corporation (AMTD)

Amazon.com, Inc. (AMZN)

Apollo Global Management, LLC (APO)

Aurinia Pharmaceuticals Inc (AUPH)

Citigroup Inc. (C)

Celanese Corporation (CE)

Cogentix Medical, Inc. (CGNT)

Cellectis S.A. (CLLS)

  • (11/14) Cellectis SA to Host Earnings Call – NEW YORK, NY / ACCESSWIRE / November 14, 2017 / Cellectis SA (NASDAQ: CLLS ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 14, 2017 at 8:30 AM Eastern Time. …

Chipotle Mexican Grill, Inc. (CMG)

Credit Suisse Group AG (CS)

ContraVir Pharmaceuticals Inc (CTRV)

Delta Air Lines, Inc. (DAL)

Deciphera Pharmaceuticals, Inc. (DCPH)

  • (11/14) Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial Results and Corporate Highlights
  • (11/14) Deciphera Pharmaceuticals, Inc. (Nasdaq: DCPH) to Ring The Nasdaq Stock Market Opening Bell – ADVISORY, Nov. 14, 2017 (GLOBE NEWSWIRE) — What:Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on developing novel treatments to improve the lives of cancer patients, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Daniel L. Flynn, Ph.D., Chief Scientific Officer and Founder, will ring the Opening Bell.  Where:Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio When:Wednesday, November 15, 2017 – 9:15 a.m. to 9:30 a.m. ET       Deciphera Pharmaceuticals, Inc. Media Contact:Gina Nugent(617) 460-3579gina@theyatesnetwork.com  Nasdaq MarketSite Media Contact:Emily Pan(646) 441-5120emily.pan@nasdaq.com Feed Information:Fiber Line (Encompass Waterfront): 4463 Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK Social Media:For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook …Full story available on Benzinga.com

Walt Disney Company (The) (DIS)

European Equity Fund, Inc. (The) (EEA)

Facebook, Inc. (FB)

Flexion Therapeutics, Inc. (FLXN)

Gilead Sciences, Inc. (GILD)

Alphabet Inc. (GOOGL)

Goldman Sachs Group, Inc. (The) (GS)

Huntington Ingalls Industries, Inc. (HII)

IAC/InterActiveCorp (IAC)

International Business Machines Corporation (IBM)

Lam Research Corporation (LRCX)

  • (11/14) Lam Research Corporation Announces $2.3 Billion Capital Return Program – Announces $2 billion share repurchase authorization 11% Increase of quarterly dividend to $0.50 from $0.45 per share FREMONT, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) — Lam Research Corporation (NASDAQ:LRCX) today announced that its Board of Directors has approved a $2 billion share repurchase authorization, with execution planned over the next 12 to 18 months; and a 11% increase of the company’s quarterly dividend. On an annualized basis, the quarterly dividend of $0.50 per share of common stock would return approximately $324 million to stockholders based on shares outstanding as of September 24, 2017.  The increased dividend payment has been declared and will be made on January 10, 2018 to holders of record on December 6, 2017.  Future dividend payments are subject to review and approval by the Board. Also, the company is authorized to repurchase up to an additional $2 billion of common stock; this authorization supplements the remaining balances from any prior authorizations.  Repurchases may be made through both public market and private transactions, and may include the use of …Full story available on Benzinga.com

Microchip Technology Incorporated (MCHP)

MannKind Corporation (MNKD)

Mosaic Company (The) (MOS)

The Madison Square Garden Company (MSG)

Mulesoft Inc (MULE)

Neurocrine Biosciences, Inc. (NBIX)

Nuance Communications, Inc. (NUAN)

NVIDIA Corporation (NVDA)

Novartis AG (NVS)

  • (11/14) Novartis launches heart drug counter-offensive – Novartis plans to plow through doubts over its canakinumab drug by asking regulators this year to approve the medicine as a treatment for a group of heart attack survivors that the Swiss drugmaker says is most likely to benefit. New analysis of Phase III data shows canakinumab cut risk of another adverse cardiac event by 25 percent in patients whose inflammatory markers fell significantly three months after starting treatment, Novartis said on Monday, adding the group represented 55 percent of those in the so-called Cantos trial. Novartis’s trial has been lauded as revolutionary for helping prove fighting inflammation – not merely lowering cholesterol – helps heart attack victims avoid future adverse events or death.
  • (11/14) Novartis Vision Drug Shows Positive Results in Phase 3 Trials
  • (11/14) Novartis: Canakinumab Reduces Cardiovascular Risk In CANTOS Phase III Trial

Oconee Federal Financial Corp. (OFED)

Overstock.com, Inc. (OSTK)

RealPage, Inc. (RP)

Sinclair Broadcast Group, Inc. (SBGI)

Southern Copper Corporation (SCCO)

Smart Global Holdings Inc (SGH)

  • (11/14) ETFs with exposure to SMART Global Holdings, Inc. : November 13, 2017 – Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to SMART Global Holdings, Inc. Here are 5 ETFs with the largest exposure to SGH-US. Comparing the performance and risk of SMART Global Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower … Read more (Read more…)

SunPower Co. (SPWR)

Square, Inc. (SQ)

Steel Dynamics, Inc. (STLD)

Switch, Inc. (SWCH)

Symantec Corporation (SYMC)

  • (11/14) Should You Buy Symantec Corporation (SYMC)? – Symantec Corporation (NASDAQ:SYMC) received a lot of attention from a substantial price movement on the NasdaqGS in the over the last few months, increasing to $34.16 at one point, andRead More…
  • (11/14) U.S. Grid Narrowly Escapes Apocalyptic Attack – A new study from IT security consulting firm Symantec shows that the U.S. power grid is at extreme risk of a detrimental cyber-attack

Tencent Holding Ltd. (TCEHY)

  • (11/14) [$$] Tencent Earnings: What to Watch – The Chinese gaming and social-media giant reports its third-quarter earnings after the market closes Wednesday. Here’s what you need to know.
  • (11/14) Naspers CEO Marks ‘Several Billion’ for Tech Investments – Naspers Ltd. is keen to continue its search for e-commerce and tech investments, with Africa’s biggest company happy to deploy a sizable war chest in its hunt for deals.
  • (11/14) How Locus landed $19M from ARTIS, Tencent – Morrisville-based Locus Biosciences – which spun out of N.C. State University and formed in 2015 – has secured $19 million in Series A funding. Locus is developing a platform in the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) space.

T-Mobile US, Inc. (TMUS)

Transenterix Inc (TRXC)

Taiwan Semiconductor Manufacturing Company Ltd. (TSM)

Wipro Limited (WIT)

Author: Lance Jepsen

For ethical purposes, I try not to hold any position in any stock I profile on GuerillaStockTrading.com unless specifically stated in the article. Owner of GuerillaStockTrading.com. Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.

Leave a Reply